[The metabolic syndrome in the daily clinic]
1Endokrinologisk Afdeling M, Odense Universitetshospital, 5000 Odense C, Denmark. henning.beck-nielsen@ouh.regionsyddanmark.dk
Abstract:
An obesity epidemic has spread all over the world during the past 30-40 years. Persons becoming viscerally obese have a large risk of developing dysmetabolism characterised by ectopic fat accumulation resulting in increased triglyceride content and reduced HDL-cholesterol in the blood, arterial hypertension and type 2 diabetes. Today, this phenotype is designated metabolic syndrome (MS). The International Diabetes Federation (IDF) has presented an operational definition making it possible to intervene against the basal components of the syndrome early in the course of the syndrome in order to reduce its serious consequences in terms of increased morbidity and mortality.
More Related Videos
06:04Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
Published on: September 27, 2024
10:31An Experimental Model of Diet-Induced Metabolic Syndrome in Rabbit: Methodological Considerations, Development, and Assessment
Published on: April 20, 2018
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
Diabetes: Symptoms, Diagnosis, and Complications
